Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Hamed Mohammadi

11 ta ish

Jahrom University of Medical Sciences

AkademScholarda batafsil koʻrsatkichlar

  1. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Maqola20216 iqtibos
    ABI

  2. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    MaqolaOchiq kirish20235 iqtibos
    ABI

  3. The role of Th17 cells in the pathogenesis and treatment of breast cancer

    Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5

    Sharh maqola20225 iqtibos
    ABI

  4. The molecular biology and therapeutic potential of Nrf2 in leukemia

    Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6

    Sharh maqola20225 iqtibos
    ABI

  5. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Maqola20214 iqtibos
    ABI

  6. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

    Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

    Sharh maqola20224 iqtibos
    ABI

  7. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

    Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

    MaqolaOchiq kirish20223 iqtibos
    ABI

  8. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses

    Sara Adibfar, Ali Masjedi, Atefeh Nazer +9

    Maqola20223 iqtibos
    ABI

  9. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Sharh maqolaOchiq kirish20222 iqtibos
    ABI

  10. Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro

    Parsa Aliabadi, Maryam Sadri, Goli Siri +8

    Maqola20222 iqtibos
    ABI

  11. Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment

    Shadi Vesaghhamedani, Farnoosh Ebrahimzadeh, Elnaz Najafi +6

    Sharh maqola20222 iqtibos
    ABI